{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:51:31Z","timestamp":1782226291862,"version":"3.54.5"},"reference-count":68,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMIR"],"published-print":{"date-parts":[[2019,11,21]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The detection of recurrence or metastasis might be challenging in patients,\nwho underwent total thyroidectomy and radioactive iodine therapy for Differentiated Thyroid Carcinoma\n(DTC), with increased serum Thyroglobulin (Tg) levels and negative 131I whole body scan\n(131I-WBS) results.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Aims:<\/jats:title>\n<jats:p>The purpose of this study was to compare the ability of Magnetic Resonance Imaging (MRI)\nand 18F-fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography (18F FDG\nPET-CT) to detect recurrence or cervical and upper mediastinal metastases in postoperative DTC\npatients who had negative 131I-WBS despite elevated serum Tg levels.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Study Design:<\/jats:title>\n<jats:p>This study has a retrospective study design.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>We evaluated cervical and upper mediastinal MRI and 18F FDG PET-CT of 32 postoperative\npatients with DTC (26 patients with papillary thyroid carcinoma and 6 patients with follicular\nthyroid carcinoma).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>We evaluated 44 lesions in 32 patients. For all lesions, the Positive Predictive Value,\n(PPV) Negative Predictive Value (NPV), sensitivity, specificity, and accuracy of MRI were 81.4%,\n76.4%, 84.6%, 72.2%, and 79.5% respectively. The PPV, NPV, sensitivity, specificity, and accuracy\nof 18F FDG PET-CT were 100.0%, 85.7%, 88.4%, 100.0%, and 93.1%, respectively.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Although we could not replace 18F FDG PET-CT, MRI might be used as an adjunct to\n18F FDG PET-CT for the evaluation of recurrent or cervical and upper mediastinal metastatic thyroid\ncancers; however, MRI is inadequate for the detection of metastases in small lymph nodes.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573405614666180718124739","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T10:57:26Z","timestamp":1574420246000},"page":"956-964","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic Capabilities of MRI Versus 18F FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, 131I-negative Local Recurrent or Metastatic Thyroid Cancer"],"prefix":"10.2174","volume":"15","author":[{"given":"Cesur","family":"Samanci","sequence":"first","affiliation":[{"name":"Department of Radiology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilmaz","family":"Onal","sequence":"additional","affiliation":[{"name":"Department of Radiology, \u0130stanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sait","family":"Sager","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sertac","family":"Asa","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fethi Emre","family":"Ustabasioglu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Alis","sequence":"additional","affiliation":[{"name":"Department of Radiology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canan","family":"Akman","sequence":"additional","affiliation":[{"name":"Department of Radiology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerim","family":"Sonmezoglu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/0002-9610(61)90527-X","volume":"102","author":"Woolner L.B.","year":"1961","unstructured":"Woolner L.B.; Beahrs O.H.; Black B.M.; McConahey W.M.; Keating F.R.; Classification and prognosis of thyroid carcinoma. A study of 885 cases observed in a thirty year period. Am J Surg 1961,102,354-387","journal-title":"Am J Surg"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/thy.2009.0110","volume":"19","author":"Cooper D.S.","year":"2009","unstructured":"Cooper D.S.; Doherty G.M.; Haugen B.R.; Revised American Thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009,19(11),1167-1214","journal-title":"Thyroid"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2638:AID-CNCR31>3.0.CO;2-1","volume":"83","author":"Hundahl S.A.","year":"1998","unstructured":"Hundahl S.A.; Fleming I.D.; Fremgen A.M.; Menck H.R.; a national cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998,83(12),2638-2648","journal-title":"Cancer"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","volume":"295","author":"Davies L.","year":"2006","unstructured":"Davies L.; Welch H.G.; Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006,295(18),2164-2167","journal-title":"JAMA"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1148\/rg.273065038","volume":"27","author":"Hoang J.K.","year":"2007","unstructured":"Hoang J.K.; Lee W.K.; Lee M.; Johnson D.; Farrell S.U.S.; Features of thyroid malignancy: pearls and pitfalls. Radiographics 2007,27(3),847-860","journal-title":"Radiographics"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/0002-9343(81)90573-8","volume":"70","author":"Mazzaferri E.L.","year":"1981","unstructured":"Mazzaferri E.L.; Young R.L.; Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1981,70(3),511-518","journal-title":"Am J Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"Jemal A.","year":"2010","unstructured":"Jemal A.; Siegel R.; Xu J.; Ward E.; Cancer statistics, 2010. CA Cancer J Clin 2010,60(5),277-300","journal-title":"CA Cancer J Clin"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/RLU.0b013e318203bb6c","volume":"36","author":"Yoshio K.","year":"2011","unstructured":"Yoshio K.; Sato S.; Okumura Y.; The local efficacy of I-131 for F-18 FDG PET positive lesions in patients with recurrent or metastatic thyroid carcinomas. Clin Nucl Med 2011,36(2),113-117","journal-title":"Clin Nucl Med"},{"key":"ref=9","first-page":"1488","volume":"80","author":"Pineda J.D.","year":"1995","unstructured":"Pineda J.D.; Lee T.; Ain K.; Reynolds J.C.; Robbins J.; Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab 1995,80(5),1488-1492","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/j.semnuclmed.2006.03.002","volume":"36","author":"Lind P.","year":"2006","unstructured":"Lind P.; Kohlf\u00fcrst S.; Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Semin Nucl Med 2006,36(3),194-205","journal-title":"Semin Nucl Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2967\/jnumed.107.047787","volume":"49","author":"Fletcher J.W.","year":"2008","unstructured":"Fletcher J.W.; Djulbegovic B.; Soares H.P.; Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008,49(3),480-508","journal-title":"J Nucl Med"},{"key":"ref=12","first-page":"870","volume":"39","author":"Gallowitsch H.J.","year":"1998","unstructured":"Gallowitsch H.J.; Mikosch P.; Kresnik E.; Unterweger O.; Gomez I.; Lind P.; Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 1998,39(5),870-875","journal-title":"J Nucl Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s11604-010-0488-z","volume":"28","author":"Bertagna F.","year":"2010","unstructured":"Bertagna F.; Biasiotto G.; Orlando E.; Bosio G.; Giubbini R.; Role of F-fluorodeoxyglucose positron emission tomography\/computed tomography in patients affected by differentiated thyroid carcinoma, high thyroglobulin level, and negative I scan: review of the literature. Jpn J Radiol 2010,28(9),629-636","journal-title":"Jpn J Radiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s002590050493","volume":"26","author":"Gr\u00fcnwald F.","year":"1999","unstructured":"Gr\u00fcnwald F.; K\u00e4licke T.; Feine U.; Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med 1999,26(12),1547-1552","journal-title":"Eur J Nucl Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1089\/thy.1999.9.591","volume":"9","author":"Toubert M.E.","year":"1999","unstructured":"Toubert M.E.; Cyna-Gorse F.; Zagdanski A.M.; Cervicomediastinal magnetic resonance imaging in persistent or recurrent papillary thyroid carcinoma: clinical use and limits. Thyroid 1999,9(6),591-597","journal-title":"Thyroid"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ejca.2008.10.028","volume":"45","author":"Schwartz L.H.","year":"2009","unstructured":"Schwartz L.H.; Bogaerts J.; Ford R.; Evaluation of lymph nodes with RECIST 1.1. Eur J Cancer 2009,45(2),261-267","journal-title":"Eur J Cancer"},{"key":"ref=17","author":"Altekruse S.F.","year":"2010","unstructured":"Altekruse S.F.; Kosary C.L.; Krapcho M.;  SEER cancer statistics review, 1975-2007 2010","journal-title":"SEER cancer statistics review, 1975-2007"},{"key":"ref=18","first-page":"71","volume":"42","author":"Schl\u00fcter B.","year":"2001","unstructured":"Schl\u00fcter B.; Bohuslavizki K.H.; Beyer W.; Plotkin M.; Buchert R.; Clausen M.; Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I scan. J Nucl Med 2001,42(1),71-76","journal-title":"J Nucl Med"},{"key":"ref=19","first-page":"1010","volume":"41","author":"Alnafisi N.S.","year":"2000","unstructured":"Alnafisi N.S.; Driedger A.A.; Coates G.; Moote D.J.; Raphael S.J.; FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma. J Nucl Med 2000,41(6),1010-1015","journal-title":"J Nucl Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1007\/s002590050158","volume":"24","author":"Dietlein M.","year":"1997","unstructured":"Dietlein M.; Scheidhauer K.; Voth E.; Theissen P.; Schicha H.; Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1997,24(11),1342-1348","journal-title":"Eur J Nucl Med"},{"key":"ref=21","first-page":"1468","volume":"37","author":"Feine U.","year":"1996","unstructured":"Feine U.; Lietzenmayer R.; Hanke J.P.; Held J.; W\u00f6hrle H.; M\u00fcller-Schauenburg W.; Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 1996,37(9),1468-1472","journal-title":"J Nucl Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1067\/mhn.2003.74","volume":"128","author":"Zimmer L.A.","year":"2003","unstructured":"Zimmer L.A.; McCook B.; Meltzer C.; Combined positron emission tomography\/computed tomography imaging of recurrent thyroid cancer. Otolaryngol Head Neck Surg 2003,128(2),178-184","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1148\/radiology.186.1.8416578","volume":"186","author":"Jabour B.A.","year":"1993","unstructured":"Jabour B.A.; Choi Y.; Hoh C.K.; Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993,186(1),27-35","journal-title":"Radiology"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1089\/105072504323030960","volume":"14","author":"Men\u00e9ndez T.E.","year":"2004","unstructured":"Men\u00e9ndez T.E.; L\u00f3pez C.M.T.; Rodr\u00edguez E.R.M.; Forga L.L.; Go\u00f1i I.M.J.; Barber\u00eda L.J.J.; Prognostic value of thyroglobulin serum levels and 131I whole-body scan after initial treatment of low-risk differentiated thyroid cancer. Thyroid 2004,14(4),301-306","journal-title":"Thyroid"},{"key":"ref=25","doi-asserted-by":"publisher","DOI":"10.2349\/biij.2.4.e56","volume":"2","author":"Sundram F.","year":"2006","unstructured":"Sundram F.; Clinical use of PET\/CT in thyroid cancer diagnosis and management. Biomed Imaging Interv J 2006,2(4)","journal-title":"Biomed Imaging Interv J"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1148\/radiology.168.3.3406405","volume":"168","author":"Auffermann W.","year":"1988","unstructured":"Auffermann W.; Clark O.H.; Thurnher S.; Galante M.; Higgins C.B.; Recurrent thyroid carcinoma: characteristics on MR images. Radiology 1988,168(3),753-757","journal-title":"Radiology"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2214\/AJR.09.4172","volume":"195","author":"Mihailovic J.","year":"2010","unstructured":"Mihailovic J.; Prvulovic M.; Ivkovic M.; Markoski B.; Martinov D.; MRI versus I whole-body scintigraphy for the detection of lymph node recurrences in differentiated thyroid carcinoma. AJR Am J Roentgenol 2010,195(5),1197-1203","journal-title":"AJR Am J Roentgenol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3174\/ajnr.A1405","volume":"30","author":"Kaplan S.L.","year":"2009","unstructured":"Kaplan S.L.; Mandel S.J.; Muller R.; Baloch Z.W.; Thaler E.R.; Loevner L.A.; The role of MR imaging in detecting nodal disease in thyroidectomy patients with rising thyroglobulin levels. AJNR Am J Neuroradiol 2009,30(3),608-612","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref=29","first-page":"1051","volume":"14","author":"Ohnishi T.","year":"1993","unstructured":"Ohnishi T.; Noguchi S.; Murakami N.; Detection of recurrent thyroid cancer: MR versus thallium-201 scintigraphy. AJNR Am J Neuroradiol 1993,14(5),1051-1057","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.clinimag.2005.01.024","volume":"29","author":"Semiz Oysu A.","year":"2005","unstructured":"Semiz Oysu A.; Ayanoglu E.; Kodalli N.; Oysu C.; Uneri C.; Erzen C.; Dynamic contrast-enhanced MRI in the differentiation of posttreatment fibrosis from recurrent carcinoma of the head and neck. Clin Imaging 2005,29(5),307-312","journal-title":"Clin Imaging"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1148\/radiology.187.3.8497625","volume":"187","author":"Dao T.H.","year":"1993","unstructured":"Dao T.H.; Rahmouni A.; Campana F.; Laurent M.; Asselain B.; Fourquet A.; Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 1993,187(3),751-755","journal-title":"Radiology"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1259\/bjr.71.851.10434907","volume":"71","author":"Hawnaur J.M.","year":"1998","unstructured":"Hawnaur J.M.; Zhu X.P.; Hutchinson C.E.; Quantitative dynamic contrast enhanced MRI of recurrent pelvic masses in patients treated for cancer. Br J Radiol 1998,71(851),1136-1142","journal-title":"Br J Radiol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1148\/radiology.200.2.8685341","volume":"200","author":"Kinkel K.","year":"1996","unstructured":"Kinkel K.; Tardivon A.A.; Soyer P.; Dynamic contrast-enhanced subtraction versus T2-weighted spin-echo MR imaging in the follow-up of colorectal neoplasm: a prospective study of 41 patients. Radiology 1996,200(2),453-458","journal-title":"Radiology"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1148\/radiology.204.1.9205223","volume":"204","author":"Kinkel K.","year":"1997","unstructured":"Kinkel K.; Ariche M.; Tardivon A.A.; Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging. Radiology 1997,204(1),55-63","journal-title":"Radiology"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1148\/radiology.189.3.8234720","volume":"189","author":"M\u00fcller-Schimpfle M.","year":"1993","unstructured":"M\u00fcller-Schimpfle M.; Brix G.; Layer G.; Recurrent rectal cancer: diagnosis with dynamic MR imaging. Radiology 1993,189(3),881-889","journal-title":"Radiology"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2214\/ajr.166.2.8553955","volume":"166","author":"Hawighorst H.","year":"1996","unstructured":"Hawighorst H.; Knapstein P.G.; Schaeffer U.; Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions. AJR Am J Roentgenol 1996,166(2),401-408","journal-title":"AJR Am J Roentgenol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1148\/radiol.11101821","volume":"263","author":"Thoeny H.C.","year":"2012","unstructured":"Thoeny H.C.; De Keyzer F.; King A.D.; Diffusion-weighted MR imaging in the head and neck. Radiology 2012,263(1),19-32","journal-title":"Radiology"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3174\/ajnr.A0491","volume":"28","author":"Abdel Razek A.A.","year":"2007","unstructured":"Abdel Razek A.A.; Kandeel A.Y.; Soliman N.; Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 2007,28(6),1146-1152","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.ijrobp.2006.09.020","volume":"67","author":"Vandecaveye V.","year":"2007","unstructured":"Vandecaveye V.; De Keyzer F.; Nuyts S.; Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 2007,67(4),960-971","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=40","first-page":"4235","volume":"23","author":"Wu H.S.","year":"2003","unstructured":"Wu H.S.; Huang W.S.; Liu Y.C.; Yen R.F.; Shen Y.Y.; Kao C.H.; Comparison of FDG-PET and technetium-99m MIBI SPECT to detect metastatic cervical lymph nodes in well-differentiated thyroid carcinoma with elevated serum HTG but negative I-131 whole body scan. Anticancer Res 2003,23(5b),4235-4238","journal-title":"Anticancer Res"},{"key":"ref=41","first-page":"1287","volume":"45","author":"Erdi Y.E.","year":"2004","unstructured":"Erdi Y.E.; Nehmeh S.A.; Pan T.; The CT motion quantitation of lung lesions and its impact on PET-measured SUVs. JNMT 2004,45,1287-1292","journal-title":"JNMT"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1053\/j.semnuclmed.2008.01.002","volume":"38","author":"Nehmeh S.A.","year":"2008","unstructured":"Nehmeh S.A.; Erdi Y.E.; Respiratory motion in positron emission tomography\/computed tomography: a review. Semin Nucl Med 2008,38(3),167-176","journal-title":"Semin Nucl Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s00259-013-2594-5","volume":"41","author":"Guerra L.","year":"2014","unstructured":"Guerra L.; Meregalli S.; Zorz A.; Comparative evaluation of CT-based and respiratory-gated PET\/CT-based Planning Target Volume (PTV) in the definition of radiation treatment planning in lung cancer: preliminary results. Eur J Nucl Med Mol Imaging 2014,41(4),702-710","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12149-013-0774-9","volume":"28","author":"Yamashita S.","year":"2014","unstructured":"Yamashita S.; Yokoyama K.; Onoguchi M.; Feasibility of deep-inspiration breath-hold PET\/CT with short-time acquisition: detectability for pulmonary lesions compared with respiratory-gated PET\/CT. Ann Nucl Med 2014,28(1),1-10","journal-title":"Ann Nucl Med"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00259-012-2248-z","volume":"40","author":"Platzek I.","year":"2013","unstructured":"Platzek I.; Beuthien-Baumann B.; Schneider M.; PET\/MRI in head and neck cancer: initial experience. Eur J Nucl Med Mol Imaging 2013,40(1),6-11","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1097\/RLU.0b013e318212c872","volume":"36","author":"Bhargava P.","year":"2011","unstructured":"Bhargava P.; Rahman S.; Wendt J.; Atlas of confounding factors in head and neck PET\/CT imaging. Clin Nucl Med 2011,36(5),e20-e29","journal-title":"Clin Nucl Med"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1097\/00005537-200111000-00006","volume":"111","author":"Gross N.D.","year":"2001","unstructured":"Gross N.D.; Weissman J.L.; Talbot J.M.; Andersen P.E.; Wax M.K.; Cohen J.I.; MRI detection of cervical metastasis from differentiated thyroid carcinoma. Laryngoscope 2001,111(11 Pt 1),1905-1909","journal-title":"Laryngoscope"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1007\/s00259-011-1866-1","volume":"38","author":"Nagarajah J.","year":"2011","unstructured":"Nagarajah J.; Jentzen W.; Hartung V.; Diagnosis and dosimetry in differentiated thyroid carcinoma using 124I PET: comparison of PET\/MRI vs. PET\/CT of the neck. Eur J Nucl Med Mol Imaging 2011,38(10),1862-1868","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40644-016-0096-y","volume":"16","author":"Hempel J.M.","year":"2016","unstructured":"Hempel J.M.; Kloeckner R.; Krick S.; Impact of combined FDG-PET\/CT and MRI on the detection of local recurrence and nodal metastases in thyroid cancer. Cancer Imaging 2016,16(1),37","journal-title":"Cancer Imaging"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3238\/arztebl.2014.0417","volume":"111","author":"Dammann F.","year":"2014","unstructured":"Dammann F.; Bootz F.; Cohnen M.; Hassfeld S.; Tatagiba M.; K\u00f6sling S.; Diagnostic imaging modalities in head and neck disease. Dtsch Arztebl Int 2014,111(23-24),417-423","journal-title":"Dtsch Arztebl Int"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/RMR.0b013e318572b76","volume":"18","author":"Miyakoshi A.","year":"2007","unstructured":"Miyakoshi A.; Dalley R.W.; Anzai Y.; Magnetic resonance imaging of thyroid cancer. Top Magn Reson Imaging 2007,18(4),293-302","journal-title":"Top Magn Reson Imaging"},{"key":"ref=52","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.12.8960","volume":"200","author":"Hoang J.K.","year":"2013","unstructured":"Hoang J.K.; Vanka J.; Ludwig B.J.; Glastonbury C.M.; Evaluation of cervical lymph nodes in head and neck cancer with CT and MRI: tips, traps, and a systematic approach. AJR Am J Roentgenol 2013,200(1)","journal-title":"AJR Am J Roentgenol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2214\/ajr.174.3.1740837","volume":"174","author":"Som P.M.","year":"2000","unstructured":"Som P.M.; Curtin H.D.; Mancuso A.A.; Imaging-based nodal classification for evaluation of neck metastatic adenopathy. AJR Am J Roentgenol 2000,174(3),837-844","journal-title":"AJR Am J Roentgenol"},{"key":"ref=54","first-page":"509","volume":"19","author":"Takashima S.","year":"1998","unstructured":"Takashima S.; Sone S.; Takayama F.; Papillary thyroid carcinoma: MR diagnosis of lymph node metastasis. AJNR Am J Neuroradiol 1998,19(3),509-513","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/archsurg.139.1.43","volume":"139","author":"Machens A.","year":"2004","unstructured":"Machens A.; Holzhausen H.J.; Dralle H.; Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg 2004,139(1),43-45","journal-title":"Arch Surg"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2214\/ajr.180.3.1800837","volume":"180","author":"Takashima S.","year":"2003","unstructured":"Takashima S.; Takayama F.; Wang J.; Kobayashi S.; Kadoya M.; Using MR imaging to predict invasion of the recurrent laryngeal nerve by thyroid carcinoma. AJR Am J Roentgenol 2003,180(3),837-842","journal-title":"AJR Am J Roentgenol"},{"key":"ref=57","author":"Edge S.B.","year":"2010","unstructured":"Edge S.B.;  American Joint Committee on Cancer AJCC cancer staging manual 2010","journal-title":"American Joint Committee on Cancer AJCC cancer staging manual"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"929","DOI":"10.2214\/ajr.177.4.1770929","volume":"177","author":"Wang J.C.","year":"2001","unstructured":"Wang J.C.; Takashima S.; Takayama F.; Tracheal invasion by thyroid carcinoma: prediction using MR imaging. AJR Am J Roentgenol 2001,177(4),929-936","journal-title":"AJR Am J Roentgenol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/00004728-200301000-00004","volume":"27","author":"Wang J.","year":"2003","unstructured":"Wang J.; Takashima S.; Matsushita T.; Takayama F.; Kobayashi T.; Kadoya M.; Esophageal invasion by thyroid carcinomas: prediction using magnetic resonance imaging. J Comput Assist Tomogr 2003,27(1),18-25","journal-title":"J Comput Assist Tomogr"},{"key":"ref=60","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.09.3965","volume":"195","author":"Seo Y.L.","year":"2010","unstructured":"Seo Y.L.; Yoon D.Y.; Lim K.J.; Locally advanced thyroid cancer: can CT help in prediction of extrathyroidal invasion to adjacent structures? AJR Am J Roentgenol 2010,195(3)","journal-title":"AJR Am J Roentgenol"},{"key":"ref=61","first-page":"1681","volume":"21","author":"Roychowdhury S.","year":"2000","unstructured":"Roychowdhury S.; Loevner L.A.; Yousem D.M.; Chalian A.; Montone K.T.; MR imaging for predicting neoplastic invasion of the cervical esophagus. AJNR Am J Neuroradiol 2000,21(9),1681-1687","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/hed.22903","volume":"35","author":"Nam I.C.","year":"2013","unstructured":"Nam I.C.; Park J.O.; Joo Y.H.; Cho K.J.; Kim M.S.; Pattern and predictive factors of regional lymph node metastasis in papillary thyroid carcinoma: a prospective study. Head Neck 2013,35(1),40-45","journal-title":"Head Neck"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/j.1445-2197.2010.05334.x","volume":"80","author":"Isaacs J.D.","year":"2010","unstructured":"Isaacs J.D.; McMullen T.P.; Sidhu S.B.; Sywak M.S.; Robinson B.G.; Delbridge L.W.; Predictive value of the Delphian and level VI nodes in papillary thyroid cancer. ANZ J Surg 2010,80(11),834-838","journal-title":"ANZ J Surg"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4174\/jkss.2011.80.5.307","volume":"80","author":"Choi J.Y.","year":"2011","unstructured":"Choi J.Y.; Choi Y.S.; Park Y.H.; Kim J.H.; Experience and analysis of level VII cervical lymph node metastases in patients with papillary thyroid carcinoma. J Korean Surg Soc 2011,80(5),307-312","journal-title":"J Korean Surg Soc"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00234-010-0743-0","volume":"52","author":"Vandecaveye V.","year":"2010","unstructured":"Vandecaveye V.; De Keyzer F.; Dirix P.; Lambrecht M.; Nuyts S.; Hermans R.; Applications of diffusion-weighted magnetic resonance imaging in head and neck squamous cell carcinoma. Neuroradiology 2010,52(9),773-784","journal-title":"Neuroradiology"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.2967\/jnumed.109.073908","volume":"51","author":"Kwee T.C.","year":"2010","unstructured":"Kwee T.C.; Takahara T.; Ochiai R.; Complementary roles of whole-body diffusion-weighted MRI and 18F-FDG PET: the state of the art and potential applications. J Nucl Med 2010,51(10),1549-1558","journal-title":"J Nucl Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1148\/radiol.12120167","volume":"266","author":"King A.D.","year":"2013","unstructured":"King A.D.; Chow K.K.; Yu K.H.; Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response. Radiology 2013,266(2),531-538","journal-title":"Radiology"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s00259-013-2351-9","volume":"40","author":"Varoquaux A.","year":"2013","unstructured":"Varoquaux A.; Rager O.; Lovblad K.O.; Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET\/CT: quantitative analysis of ADC and SUV. Eur J Nucl Med Mol Imaging 2013,40(6),842-852","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Current Medical Imaging Formerly Current Medical Imaging Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/163870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T11:30:04Z","timestamp":1576323004000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/163870\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":68,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,11,21]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573405614666180718124739","relation":{},"ISSN":["1573-4056"],"issn-type":[{"value":"1573-4056","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,21]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-02-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}